How Biomarkers will Transform epilepsy care in the 2020s
We asked Professor Deb Pal, from King's College London, who was awarded an ERUK pilot gran [...]
We asked Professor Deb Pal, from King's College London, who was awarded an ERUK pilot gran [...]
Children whose mothers used antiepileptic drugs (AEDs) while pregnant are not more likely [...]
Adhering to antiepileptic drugs (AEDs) improves seizure control but can also enhance quali [...]
Adamas, a pharmaceutical company based in California, has announced the completion of a Ph [...]
The pharmaceutical company Neurelis Inc. recently announced that the US Food and Drug Admi [...]
The outcome of antiepileptic drug (AED) therapy in people with epilepsy related to blood v [...]
A study published in the scientific journal, Epilepsia, shows that electronic diaries may [...]
Women with epilepsy who are overweight are at a higher risk of developing complications du [...]
The use of antiepileptic drugs (AEDs) may decrease the levels of folic acid and vitamin B1 [...]
Valproic acid may be more effective than lamotrigine as a first-line drug for the treatmen [...]
Please note that Epilepsy Research UK does not endorse/promote individual epilepsy treatme [...]
Paediatric researchers from Taiwan, who compared the effects of old and new antiepileptic [...]
Please note that Epilepsy Research UK does not endorse/promote individual epilepsy treatme [...]
Long-term use of antiepileptic drugs (AEDs) is associated with vitamin D deficiency, even [...]
Yesterday the Royal College of Obstetricians and Gynaecologists published the first editio [...]
New research has demonstrated the potential benefits that the antiepileptic drug (AED) bri [...]
A new study has demonstrated the effectiveness of intravenous lacosamide in the treatment of various forms of epilepsy.
Researchers have found a way of redesigning an established epilepsy therapy to improve its performance while reducing its side effects.
A new study has highlighted some of the factors that lead to epilepsy patients not taking their medication as prescribed by their doctors.
Briviact, a new add-on treatment for partial onset seizures, has been launched in the UK.